IP Library Granted Patent US 11,697,028
Granted Patent B2
US 11,697,028 · App. 17/942,353 · Granted Jul 11, 2023

Adjustable illuminator for photodynamic therapy and diagnosis

Inventors: Thomas Boyajian (Wilmington, MA); Mark Carota (Chelmsford, MA); Brian Mazejka (Salem, NH)
Assignee: DUSA PHARMACEUTICALS, INC.
A61N5/062A61B5/0064A61B5/0082A61N2005/0626A61N2005/0633A61N2005/0642A61N2005/0651A61N2005/0652A61N2005/0662A61N2005/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,697,028
App. No.
17/942,353
Granted
Jul 11, 2023
Kind
B2
Abstract

An adjustable illuminator for photodynamically diagnosing or treating a surface includes a plurality of first panels and at least one second panel. The plurality of first panels have wider widths and the at least one second panel has a narrower width. The narrower width is less than the wider widths. The illuminator further includes a plurality of light sources, each mounted to one of the plurality of first panels or the at least one second panel and configured to irradiate the surface with substantially uniform intensity visible light. The plurality of first panels and the at least one second panel are rotatably connected. The at least one second panel is connected on each side to one of the plurality of first panels. The second panel acts as a “lighted hinge” to reduce or eliminate optical dead spaces between adjacent panels when the illuminator is bent into a certain configuration.

Claims (51)

1. A system for photodynamically diagnosing or treating a patient, comprising:

an illuminator comprising five panels connected by hinged structures on inner side surfaces of adjacent panels; and

light sources disposed on surfaces of the five panels, the illuminator being configured to uniformly illuminate a treatment surface of the patient via the light sources,

one of the five panels being positioned as a center panel configured to face the treatment surface, and two or more of the five panels being configured to be angled relative to the center panel,

wherein the five panels are positioned to allow treatment within approximately four inches of the treatment surface, and

wherein each of the five panels has two first edges and two second edges shorter than the two first edges, and the light sources are arranged such that a higher intensity of light is emitted proximate the second edges compared to the intensity of light emitted not proximate the second edges.

2. The system of claim 1 , wherein the illuminator is configured to output red light at a dose of 30 J/cm 2 to 150 J/cm 2 .

3. The system of claim 1 , wherein the illuminator is configured to output light at an irradiance density of 10 mW/cm 2 to 30 mW/cm 2 .

4. The system of claim 1 , wherein a plurality of the light sources are configured to emit light having a wavelength in a range of 400 nm to 700 nm.

5. A method of photodynamically diagnosing or treating a patient, comprising:

administering 5-aminolevulinic acid (ALA) to the patient;

positioning an illuminator proximate to the patient, the illuminator comprising five panels connected by hinged structures on inner side surfaces of adjacent panels; and

uniformly illuminating a treatment surface of the patient with light sources disposed on the five panels of the illuminator, the five panels being positioned to allow treatment within approximately four inches of the treatment surface,

wherein each of the five panels has two first edges and two second edges shorter than the two first edges, and the light sources are arranged such that a higher intensity of light is emitted proximate the second edges compared to the intensity of light emitted not proximate the second edges.

6. The method of claim 5 , wherein the illuminating comprises outputting red light during at least part of the time when the treatment surface is illuminated.

7. The method of claim 5 , wherein the illuminating comprises outputting blue light during at least part of the time when the treatment surface is illuminated.

8. The method of claim 5 , further comprising changing intensities of the light sources of the illuminator with a controller in accordance with information received from at least one sensor relating to a curvature of the treatment surface.

9. The method of claim 5 , wherein:

the illuminator comprises at least three first panels having first widths, at least two second panels having second widths, wherein each of the second widths of the at least two second panels is narrower than each of the first widths of the at least three first panels; and

the at least three first panels and the at least two second panels are connected in an alternating manner such that each of the at least two second panels has a first lateral side connected to a respective one of the at least three first panels and a second lateral side connected to another respective one of the at least three first panels.

10. The method of claim 5 , further comprising determining a size of the treatment surface of the patient using a sensor.

11. The method of claim 10 , further comprising adjusting an overall light dose with a controller based on the determined size of the treatment surface.

12. The method of claim 10 , further comprising adjusting positioning of panels with at least one actuator based on the determined size of the treatment surface.

13. The method of claim 5 , further comprising determining a shape of the treatment surface of the patient using a sensor.

14. The method of claim 13 , further comprising adjusting an overall light dose with a controller based on the determined shape of the treatment surface.

15. The method of claim 13 , further comprising adjusting positioning of panels with at least one actuator based on the determined shape of the treatment surface.

16. A system for photodynamically diagnosing or treating a patient, comprising:

a mobile base supported by at least four wheels;

a pillar perpendicular to the base;

a controller disposed to be supported by the pillar;

an arm mounted to a top portion of the pillar; and

an illuminator connected at an end of the arm, the arm being hinged to allow adjustment of a position of the illuminator relative to the base, the illuminator comprising:

five panels connected by hinged structures to allow continuous illumination across the five panels, wherein the five panels are individually configurable to control illumination from each of the five panels,

light sources disposed on surfaces of the five panels, the illuminator being configured to uniformly illuminate a treatment surface of the patient via the light sources, the light sources being configured to output light uniformly during at least part of a time when the treatment surface is illuminated, each of the five panels having two first edges and two second edges shorter than the two first edges, the light sources arranged such that a higher intensity of light is emitted proximate the second edges compared to the intensity of light emitted not proximate the second edges, and

one or more fans mounted to at least one of the five panels.

17. The system of claim 16 , wherein one of the five panels is positioned as a center panel configured to face the treatment surface, and two or more of the five panels are configured to be angled relative to the center panel.

18. The system of claim 16 , wherein the light sources are configured to output blue light during at least part of the time when the treatment surface is illuminated.

19. The system of claim 16 , wherein the light sources are configured to output red light during at least part of the time when the treatment surface is illuminated.

20. A system for photodynamically diagnosing or treating a patient, comprising:

an illuminator comprising five panels connected by hinged structures on inner side surfaces of adjacent panels, wherein the illuminator is configured to output light at a variable irradiance density during treatment; and

light sources disposed on surfaces of the five panels, the illuminator being configured to uniformly illuminate a treatment surface of the patient via the light sources,

one of the five panels being positioned as a center panel configured to face the treatment surface, and two or more of the five panels being configured to be angled relative to the center panel,

wherein the five panels are positioned to allow treatment within approximately four inches of the treatment surface, and

wherein each of the five panels has two first edges and two second edges shorter than the two first edges, and the light sources are arranged such that a higher intensity of light is emitted proximate the second edges compared to the intensity of light emitted not proximate the second edges.

21. A system for photodynamically diagnosing or treating a patient, comprising:

an illuminator comprising five panels connected by hinged structures on inner side surfaces of adjacent panels; and

light sources disposed on surfaces of the five panels, the illuminator being configured to uniformly illuminate a treatment surface of the patient via the light sources,

one of the five panels being positioned as a center panel configured to face the treatment surface, and two or more of the five panels being configured to be angled relative to the center panel,

wherein the five panels are positioned to allow treatment within approximately four inches of the treatment surface,

wherein the five panels are individually configurable to control illumination from each of the five panels, and

wherein each of the five panels has two first edges and two second edges shorter than the two first edges, and the light sources are arranged such that a higher intensity of light is emitted proximate the second edges compared to the intensity of light emitted not proximate the second edges.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2024
From: BOYAJIAN, THOMAS; CAROTA, MARK; MAZEJKA, BRIAN
To: DUSA PHARMACEUTICALS, INC.
Reel/Frame 067409/0242 →
MERGER Recorded May 14, 2024
From: DUSA PHARMACEUTICALS, INC.
To: SUN PHARMACEUTICAL INDUSTRIES, INC.
Reel/Frame 067409/0615 →
Continuity (4)
Continuation 16791004 · Feb 14, 2020
Division 15292731 · Oct 13, 2016
Provisional Application 62241902 · Oct 15, 2015
Related Publication 20230001227A1 · Jan 5, 2023
Cited By (2)
US 12,290,700 US 12,296,011